{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T17:49:49Z","timestamp":1788112189688,"version":"build-2803163510"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2321-B-002-068"],"award-info":[{"award-number":["108-2321-B-002-068"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2320-B-002-025"],"award-info":[{"award-number":["109-2320-B-002-025"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["UN110-014"],"award-info":[{"award-number":["UN110-014"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Hereditary transthyretin amyloidosis (ATTRv) encompasses different phenotypes among various genotypes. The analysis of the natural history and risk factors of faster progression in different genotypes would refine the treatment strategy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The clinical manifestations of ATTRv from A97S (p.A117S) of Taiwanese and late-onset V30M (p.V50M) of Japanese were compared. An autopsy study of A97S was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There existed three unique features in the A97S cohort compared to the V30M cohort: (1) dysphagia, (2) carpal tunnel syndrome (CTS), and (3) onset age. First, dysphagia was common in A97S (53.4%) but not in V30M and served as a contributor to fast disease progression. All phases of swallowing were affected. In the autopsy pathology, there were extensive amyloid deposits in the viscera and nerves of the tongue, larynx, and esophagus. In A97S, 45 patients (43.3%) had a history of CTS before the onset of length-dependent symptoms by 3 years. The amyloid deposition was more prominent in the median nerve than that in the transverse carpal ligament. The onset age at different stages was younger in the A97S cohort than the V30M cohort by 4\u20135 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These phenotypic characteristics together with autopsy pathology in A97S are distinct from V30M. Early dysphagia in A97S correlated with fast progression. In A97S, median neuropathy leading to CTS might be in a continuous spectrum of ATTRv course rather than an independent disease entity. Such observations may serve as a foundation to explore and analyze unique phenotypes among various genotypes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2021.786322","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T07:37:33Z","timestamp":1643182653000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M"],"prefix":"10.3389","volume":"13","author":[{"given":"Hsueh-Wen","family":"Hsueh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chao","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koping","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Ming","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Tsang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1212\/WNL.0000000000001870","article-title":"Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study.","volume":"85","author":"Adams","year":"2015","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis.","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.","volume":"15","author":"Adams","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/WCO.0000000000000289","article-title":"First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy.","volume":"29","author":"Adams","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians.","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"key":"B7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis.","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1475-097x.1993.tb00317.x","article-title":"Oesophageal dysfunction in familial amyloidosis with polyneuropathy.","volume":"13","author":"Bjerle","year":"1993","journal-title":"Clin. Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/jns.12180","article-title":"Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease.","volume":"21","author":"Buades-Rein\u00e9s","year":"2016","journal-title":"J. Peripher. Nerv. Syst."},{"key":"B11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/jnnp-2015-310907","article-title":"A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK.","volume":"87","author":"Carr","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1751-7133.2012.00303.x","article-title":"Diflunisal for ATTR cardiac amyloidosis.","volume":"18","author":"Casta\u00f1o","year":"2012","journal-title":"Congest Heart Fail"},{"key":"B13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/acn3.778","article-title":"Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan.","volume":"6","author":"Chao","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/01.jnen.0000171654.24836.bd","article-title":"Reinnervation of muscular targets by nerve regeneration through guidance conduits.","volume":"64","author":"Chiang","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/ene.14698","article-title":"Early changes of nerve integrity in preclinical carriers of hereditary transthyretin Ala117Ser amyloidosis with polyneuropathy.","volume":"28","author":"Chiang","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"e1999","DOI":"10.1212\/WNL.0000000000006543","article-title":"Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.","volume":"91","author":"Coelho","year":"2018","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/mus.20644","article-title":"Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal.","volume":"35","author":"Concei\u00e7\u00e3o","year":"2007","journal-title":"Muscle Nerve"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz173","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS).","author":"Damy","year":"2019","journal-title":"Eur. Heart J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.mayocp.2019.02.012","article-title":"Renal infarction and its consequences for renal function in patients with cardiac amyloidosis.","volume":"94","author":"Dang","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1007\/s00415-013-7124-7","article-title":"Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.","volume":"260","author":"Dohrn","year":"2013","journal-title":"J. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/acn3.51328","article-title":"Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study.","volume":"8","author":"Du","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B22","author":"Dumitru","year":"2002","journal-title":"Electrodiagnostic Medicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13506129.2012.750604","article-title":"ATTR amyloid in the carpal tunnel ligament is frequently of wildtype transthyretin origin.","volume":"20","author":"Gioeva","year":"2013","journal-title":"Amyloid"},{"key":"B24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11010-008-9841-2","article-title":"Transthyretin is up-regulated by sex hormones in mice liver.","volume":"317","author":"Gon\u00e7alves","year":"2008","journal-title":"Mol. Cell Biochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.mayocp.2019.10.036","article-title":"Regression of bone-tracer uptake in cardiac transthyretin amyloidosis.","volume":"95","author":"Groothof","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1468-1331.1998.520211.x","article-title":"Bulbar palsy in senile onset familial amyloid polyneuropathy (30Val\u2013>Met): transthyretin-amyloid deposits in the hypoglossal nerve root.","volume":"5","author":"Ikeda","year":"1998","journal-title":"Eur. J. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1212\/wnl.58.7.1001","article-title":"Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.","volume":"58","author":"Ikeda","year":"2002","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/jnnp.2010.218958","article-title":"Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation.","volume":"82","author":"Koike","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/archneur.59.11.1771","article-title":"Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form.","volume":"59","author":"Koike","year":"2002","journal-title":"Arch. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1212\/01.wnl.0000132966.36437.12","article-title":"Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.","volume":"63","author":"Koike","year":"2004","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jnnp-2011-301299","article-title":"Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas.","volume":"83","author":"Koike","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis.","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/13506129.2019.1582479","article-title":"Ala97Ser mutation is common among ethnic Chinese Malaysians with transthyretin familial amyloid polyneuropathy.","volume":"26","author":"Low","year":"2019","journal-title":"Amyloid"},{"key":"B34","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/ana.24519","article-title":"Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.","volume":"78","author":"Mariani","year":"2015","journal-title":"Ann. Neurol."},{"key":"B35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy.","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies.","volume":"22","author":"Milandri","year":"2020","journal-title":"Eur. J. Heart Fail"},{"key":"B37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/13506129.2012.661806","article-title":"Permanent dysphagia in familial amyloid polyneuropathy (ATTRVal30Met).","volume":"19","author":"Monteiro","year":"2012","journal-title":"Amyloid"},{"key":"B38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10286-019-00628-6","article-title":"Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.","volume":"29","author":"Obici","year":"2019","journal-title":"Clin. Auton Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12883-021-02243-3","article-title":"Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.","volume":"21","author":"Pasutharnchat","year":"2021","journal-title":"BMC Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2019.05.030","article-title":"Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: characterization of Brazilian subjects from the THAOS registry.","volume":"403","author":"Pinto","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/13506129.2017.1313222","article-title":"Amyloid detection in the transverse carpal ligament of patients with hereditary ATTR V30M amyloidosis and carpal tunnel syndrome.","volume":"24","author":"Sam\u00f5es","year":"2017","journal-title":"Amyloid"},{"key":"B42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ajmg.1320600606","article-title":"Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in P\u00f3voa do Varzim and Vila do Conde (north of Portugal).","volume":"60","author":"Sousa","year":"1995","journal-title":"Am. J. Med. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.mayocp.2018.06.016","article-title":"A Patient with hereditary ATTR and a novel AGel p.Ala578Pro amyloidosis.","volume":"93","author":"Sridharan","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"B44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/ene.13845","article-title":"Upper limb onset of hereditary transthyretin amyloidosis is common in non-endemic areas.","volume":"26","author":"Th\u00e9audin","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1212\/WNL.0000000000008320","article-title":"Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis.","volume":"93","author":"Yamashita","year":"2019","journal-title":"Neurology"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.786322\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T07:37:40Z","timestamp":1643182660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.786322\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":45,"alternative-id":["10.3389\/fnagi.2021.786322"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2021.786322","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"article-number":"786322"}}